Press release
Global Ovarian Cancer Drugs Market is expected to grow in near future | Market Opportunities and Forecast, 2017-2022
According to OMR analysis, the Global Ovarian Cancer Drugs Market is estimated to grow at a significant CAGR during the forecast period (2017-2022). The market is boosted by the increasing incidence of ovarian cancer and rising aged women population. The need for more effective treatment options is pushing the growth of the global ovarian cancer drugs market.A full report of Global Ovarian Cancer Drugs Market is available at https://www.omrglobal.com/industry-reports/ovarian-cancer-drugs-market/
Furthermore, the Global Ovarian Cancer Drugs Market is segmented on the basis of cancer type, treatment, and drugs. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.
Market Segmentation
1. Global Ovarian Cancer Drugs Market, by Cancer Type
• Epithelial Ovarian Tumors
• Ovarian Germ Cell Tumors
• Ovarian Stromal Tumors
• Primary Peritoneal Carcinoma
2. Global Ovarian Cancer Drugs Market, by Treatment
• Chemotherapy
• Targeted Therapy
• Radiation Therapy
• Immunotherapy
• Harmonal Therapy
• Surgery
3. Global Ovarian Cancer Drugs Market, by Drugs
• Alkeran (Melphalan)
• Avastin (Bevacizumab)
• Carboplatin
• Clafen (Cyclophosphamide)
• Cisplatin
• Cyclophosphamide
• Cytoxan (Cyclophosphamide)
• Doxorubicin Hydrochloride
• DOX-SL (Doxorubicin Hydrochloride Liposome)
• DOXIL (Doxorubicin Hydrochloride Liposome)
• EVACET (Doxorubicin Hydrochloride Liposome)
• Gemcitabine Hydrochloride
Region Covered
• North America (US and Canada)
• Europe (UK, Germany, France, Spain, and Italy)
• Asia-Pacific (China, India, South Korea, and Japan)
• Rest of the World (Middle East & Africa and Latin America)
Company Profile
• Abraxane
• Alkeran
• ALZA
• AMGEN
• AstraZeneca
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Co.
• Celgene
• Clovis Oncology
• Delmar Pharmaceuticals Inc.
• Doxil
• Eli Lilly and Co.
• Exelixis
• F. Hoffmann-La Roche Ltd.
• Genentech, Inc.
• GlaxoSmithKline PLC
• Janssen Pharmaceuticals, Inc.
• Lynparza
• Novartis Pharmaceuticals Corp.
• Novogen, Inc.
For related reports please visit https://www.omrglobal.com/reports-category/pharmaceuticals/
For more update follow LinkedIn https://www.linkedin.com/company/omr-global-research/
About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.
Contact us
Orion Market Research Pvt. Ltd.
Anurag Tiwari
Email: info@omrglobal.com
India: +91 7803040404
Global:+1 6467557667
Indore-India-452010
Web: www.omrglobal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Ovarian Cancer Drugs Market is expected to grow in near future | Market Opportunities and Forecast, 2017-2022 here
News-ID: 1681447 • Views: …
More Releases from Orion Market Research

Cleaning Robot Market Global Rising Demand & Huge Scope Till 2032
In 2023, the global cleaning robot market was valued at approximately USD 13.76 billion. It is projected to reach around USD 92.67 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 23.6% from 2024 to 2032.
Cleaning Robot Market Overview
The cleaning robot market has experienced significant growth, driven by increasing consumer demand for automated and efficient cleaning solutions in both residential and commercial settings. Advancements in…

Aesthetic Lasers Market - Industry Trends and Forecast to 2032 Growth, Share, Va …
In 2023, the global aesthetic lasers market was valued at approximately USD 2.63 billion. Projections suggest it will reach around USD 5.39 billion by 2032, reflecting a compound annual growth rate (CAGR) of 16.6% from 2024 to 2032.
Aesthetic Lasers Market Overview
The aesthetic lasers market has been experiencing significant growth, driven by technological advancements in laser treatments and a rising preference for non-invasive cosmetic procedures. Factors such as…

Environmental Testing Equipment Market - Industry Trends and Forecast to 2032
In 2023, the global environmental testing equipment market was valued at approximately USD 1.28 billion. It is projected to reach around USD 2.43 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.38% from 2024 to 2032.
Environmental Testing Equipment Market Overview
The environmental testing equipment market has been experiencing steady growth, driven by increasing environmental awareness and stringent regulatory compliance requirements. The rising emphasis on environmental sustainability…

Drone Software Market - Industry Trends and Forecast to 2032
In 2023, the global drone software market was valued at approximately USD 6.2 billion. It is projected to reach around USD 26.4 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 17.5% from 2024 to 2032.
Drone Software Market Overview
The drone software market has experienced significant growth, driven by the expanding applications of drones across various sectors such as agriculture, construction, defense, and logistics. Advancements in artificial…
More Releases for Ovarian
Polycystic Ovarian Syndrome Treatment Market Report
The findings reviewed by GME stated that the Global Polycystic Ovarian Syndrome Treatment Market will expand with a CAGR value of 5.2 percent from 2021 to 2026. The rising incidence of PCOS increased understanding among a group of patients, and the growing acceptance of standard treatment boosts the PCOS treatment industry growth over the projected timeframe. Furthermore, the research and development of PCOS are predicted to aid in market growth.
Browse…
How deadly is Ovarian Cancer?
Ovarian Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025
Ovarian cancer is a cancer that forms in or on an ovary. It results in abnormal cells that have the ability to invade or spread to other parts of the body.
The global Ovarian Cancer Treatment Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025,…
Polycystic Ovarian Syndrome - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Polycystic Ovarian Syndrome - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Polycystic Ovarian Syndrome - Pipeline Review, H2 2017, provides an overview of the Polycystic Ovarian Syndrome (Women's Health) pipeline landscape.
Polycystic ovary syndrome (PCOS) is a common hormonal disorder among women of reproductive age. Symptoms…
Ovarian Cancer Drugs Market Report : 2017
Reports And Markets Publish a New Market Research Report On –"Ovarian Cancer Drugs Market Report : 2017"
Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/united-states-ovarian-cancer-drugs-market-report-2017-1541150
In this report, the United States Ovarian Cancer Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United…
Ovarian Cancer - Pipeline Review, H1 2017
Report Hive Market Research Released a New Research Report of 2027 pages on Title " Ovarian Cancer - Pipeline Review, H1 2017 "with detailed Analysis, Forecast and Strategies.
Ovarian Cancer - Pipeline Review, H1 2017
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Pipeline Review, H1 2017, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape.
Ovarian cancer is any cancerous growth that may occur in different…
Ovarian Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Ovarian Cancer - Heat Map and Analysis to its growing collection of premium market research reports.
Ovarian Cancer (OC) is the fifth most common malignancy diagnosed in women, and the most common gynecological cancer, with an estimated 225,000 new cases diagnosed globally in 2008. Rates are particularly high in developed countries, and especially in Northern Europe. However, substantial improvements in…